Trial · NCT03019575
Adverse events53
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 53 of 53
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pruritus genital | Reproductive system and breast disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
| other | Scrotal disorder | Reproductive system and breast disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
| other | Spermatocele | Reproductive system and breast disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 5 | 17 | 6 |
| other | Varicocele | Reproductive system and breast disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
| other | Nasal congestion | Respiratory, thoracic and mediastinal disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
| other | Rhinitis allergic | Respiratory, thoracic and mediastinal disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
| other | Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 2 | 17 | 2 |
| other | Acanthosis nigricans | Skin and subcutaneous tissue disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
| other | Acne | Skin and subcutaneous tissue disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
| other | Dermatitis contact | Skin and subcutaneous tissue disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
| other | Hot flush | Vascular disorders | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
| serious | Craniopharyngioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Corifollitropin Alfa (CFA)+Human Chorionic Gonadotropin (hCG) | 1 | 17 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03019575/events?page=3